SCHEMBL13746646

SCHEMBL13746646

CCCOc1nc(N)nc2c1ncn2CCOCN[C@@H](Cc1ccccc1)C(=O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINA3 P01011 1/20 0.46
MGMT P16455 1/20 0.42
HDAC1 Q13547 2/20 0.38
ADORA2A P29274 5/20 0.38
ADORA1 P30542 4/20 0.38
TMIGD3 P0DMS9 3/20 0.38
CYP2C19 P33261 1/20 0.38
HPRT1 P00492 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ADORA2B P29275 1/20 0.36
ELANE P08246 1/20 0.36
TP53 P04637 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
HDAC2 Q92769 1/20 0.35
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
SLC29A1 Q99808 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2606931 0.88 SERPINA3 (0.50) SERPINA3MGMTHDAC1ADORA2AADORA1
SCHEMBL13746593 0.87 SERPINA3 (0.45) SERPINA3MGMTHDAC1ADORA2AADORA1
SCHEMBL2607029 0.85 SERPINA3 (0.47) SERPINA3MGMTHDAC1ADORA2AADORA1
SCHEMBL13746666 0.84 CYP2C19 (0.40) SERPINA3MGMTHDAC1CYP2C19HPRT1
SCHEMBL2606986 0.82 SERPINA3 (0.51) SERPINA3MGMTHDAC1ADORA2AADORA1
SCHEMBL2606933 0.82 SERPINA3 (0.49) SERPINA3MGMTHDAC1ADORA2AADORA1
SCHEMBL2606973 0.81 SERPINA3 (0.51) SERPINA3MGMTHDAC1ADORA2AADORA1
SCHEMBL13746845 0.79 CYP2C19 (0.39) SERPINA3MGMTHDAC1CYP2C19HPRT1
SCHEMBL13747298 0.78 SERPINA3 (0.41) SERPINA3MGMTHDAC1CYP2C19HPRT1
SCHEMBL2606916 0.77 SERPINA3 (0.47) SERPINA3MGMTHDAC1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009105513-A2 NOVEL COMPOUNDS AND METHODS FOR THERAPY GILEAD SCIENCES, INC. (US) 2009-08-27 WO disclosed